Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other...
Key Features to Consider When Implementing IRT for Clinical Trials In recent years, Interactive Response Technology (IRT) has become an...
The Food and Drug Administration (FDA) has recently cleared the Phase 1B Investigational New Drug (IND) application for TCB-008, a...
Clinical trials are an essential part of the drug development process, providing valuable data on the safety and efficacy of...
The Food and Drug Administration (FDA) has recently granted Fast Track designation for an investigational food allergy immunotherapy, marking a...
The Food and Drug Administration (FDA) has recently granted RTI Surgical Inc. Investigational Device Exemption (IDE) approval for a clinical...
Promising Results from Roche’s Drug Phase II Trial for Lupus Nephritis Patients Lupus nephritis is a severe and potentially life-threatening...
The Food and Drug Administration (FDA) has recently approved a Phase II study of Silmitasertib, a potential treatment for community-acquired...
New Findings from Phase 3 INDIGO Study Highlight Vorasidenib’s Potential to Revolutionize Treatment for IDH-Mutant Diffuse Glioma A groundbreaking study,...
Novo Nordisk Initiates Clinical Trial Comparing Pipeline Drug CagriSema with Recently Approved Zepbound Novo Nordisk, a global healthcare company specializing...
Arrowhead Pharmaceuticals, a biopharmaceutical company specializing in the development of RNA interference (RNAi) therapeutics, recently shared exciting data on two...
Is uniQure on its way to becoming a leading biotech company in gene therapy? Gene therapy, a revolutionary field in...
Cell therapy is a rapidly growing field in the biotechnology industry, with the potential to revolutionize the treatment of various...
Is GSK’s Myelofibrosis Treatment Likely to Receive EU-First Approval? GlaxoSmithKline (GSK), a leading pharmaceutical company, has been making significant strides...
Ocugen Administers First Dose to Patient in Study on Stargardt Disease Ocugen, a biopharmaceutical company focused on developing gene therapies...
